Subsequent studies on interferon-α (IFN-α), a cytokine, further demonstrated antitumoral activity in melanoma, hairy cell leukemia, renal cell carcinoma (RCC), and other solid tumors [6]. This evidence concerns the gene IFNA2 and renal cell carcinoma.